Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 683
|
SVP, Therap & Clin Prog Dev | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 10,000 | $9.50 | 19,647 |
Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 683
|
SVP, Therap & Clin Prog Dev | Form 4 | Open market or private sale of non-derivative or derivative security | 10,000 | $20.05 | 9,647 |
Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 683
|
SVP, Therap & Clin Prog Dev | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 10,000 | -- | -- |
Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 683
|
SVP, Therap & Clin Prog Dev | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 24,226 | -- | 7,463 |
Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 683
|
SVP, Therap & Clin Prog Dev | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 3,100 | -- | 4,363 |
Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 683
|
SVP, Therap & Clin Prog Dev | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 900 | -- | 3,463 |
Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 683
|
SVP, Therap & Clin Prog Dev | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 115 | -- | 3,348 |
Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 683
|
SVP, Therap & Clin Prog Dev | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 100 | -- | 3,248 |
Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 683
|
SVP, Therap & Clin Prog Dev | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 300 | -- | 2,948 |
Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 683
|
SVP, Therap & Clin Prog Dev | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 700 | -- | 2,248 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.